financetom
Business
financetom
/
Business
/
Google Pixel 3a, 3a XL will be way more expensive in India compared to US. Here's how
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Google Pixel 3a, 3a XL will be way more expensive in India compared to US. Here's how
May 8, 2019 2:09 PM

Finally, Google Pixel 3a and Pixel 3a XL were unveiled in the US on Tuesday during Google's I/O 2019 address. Both the smartphones are priced at $399 (roughly Rs 27,791) and $479 (roughly Rs 33,500) respectively.

However, the Google Pixel 3a and Pixel 3a XL will be available in India at a price of Rs 39,999 and Rs 44,999 respectively in Flipkart, which is not cheap by any Indian standards. Both smartphones will be available from May 15, 2019, for buyers.

According to BGR, Google imports Pixel 3a and Pixel 3a XL and thus it pays import duty but even after that, the pricing seems to be on the higher end of the spectrum. Pixel 3a’s cost must have been determined at over Rs 100 for a dollar while that of Pixel 3a XL at over Rs 93 for a dollar.

Google Pixel 3a features a 3.5mm headphone jack and an OLED display. The smartphone runs a 10nm Snapdragon 670 SoC paired with 4GB RAM and 64GB onboard storage.

For the camera lovers, you get a 12-megapixel rear snapper of f/1.8 aperture. Google is using the same Sony IMX363 sensor as on the Pixel 3 series. Up front, there is a single 8-megapixel sensor (f/2.0 aperture). Camera features like Playground, Night Sight, Portrait Mode and HDR+ are available on the smartphone.

Also read

: Google launches Pixel 3a, 3a XL. Here's the first look of the smartphones

First Published:May 8, 2019 11:09 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SEALSQ Joins Forces With Landis+Gyr To Secure North America's Energy Grid
SEALSQ Joins Forces With Landis+Gyr To Secure North America's Energy Grid
Oct 13, 2025
SEALSQ Corp ( LAES ) and Landis+Gyr ( LGYRF ) are expanding their partnership to strengthen cybersecurity in North America’s energy infrastructure. Landis+Gyr ( LGYRF ) will implement SEALSQ’s IneS Public Key Infrastructure (PKI) solution in its electric and gas meter manufacturing facilities to enhance device authentication and data protection. The collaboration builds on earlier projects in Asia and Europe,...
Apyx Medical Seeks Clearance for Ayon System Label Expansion
Apyx Medical Seeks Clearance for Ayon System Label Expansion
Oct 13, 2025
10:47 AM EDT, 10/13/2025 (MT Newswires) -- Apyx Medical ( APYX ) said Monday it has submitted a new premarket notification to the US Food and Drug Administration for the label expansion of its Ayon Body Contouring System to include power liposuction. Apyx said getting market clearance for power liposuction would solidify Ayon's position as an integrated body contouring system,...
Texas Instruments is Facing Tariff Headwinds to Demand Improvement, BofA Says
Texas Instruments is Facing Tariff Headwinds to Demand Improvement, BofA Says
Oct 13, 2025
10:52 AM EDT, 10/13/2025 (MT Newswires) -- Texas Instruments ( TXN ) has high-quality assets, but near- and medium-term demand improvement in the industrial economy could be dampened due to global tariffs, BofA Securities said in a Monday research report. The company also has limited exposure to the artificial intelligence capital expenditure cycle and has a rich valuation despite relatively...
Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients
Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients
Oct 13, 2025
Moderna Inc ( MRNA ). announced on Sunday that its clinical, safety, and translational data from its Phase 1/2 study evaluating mRNA-4359 in combination with pembrolizumab in patients with checkpoint inhibitor-resistant/refractory (CPI-R/R) melanoma will be presented at the 2025 European Society for Medical Oncology Congress. mRNA-4359 is an investigational immune-evasion targeted cancer antigen therapy (CAT) that encodes epitopes of two...
Copyright 2023-2026 - www.financetom.com All Rights Reserved